VALIANTORG

Valiant Organics Share Price

₹413.70 -5.6 (-1.34%)

10 Jul, 2025 22:06

SIP TrendupStart SIP in VALIANTORG

Start SIP

Performance

  • Low
  • ₹411
  • High
  • ₹428
  • 52 Week Low
  • ₹227
  • 52 Week High
  • ₹508
  • Open Price₹426
  • Previous Close₹419
  • Volume11,686

Investment Returns

  • Over 1 Month -5.71%
  • Over 3 Month + 16.09%
  • Over 6 Month + 30.9%
  • Over 1 Year -1.77%
SIP Lightning

Smart Investing Starts Here Start SIP with Valiant Organics for Steady Growth!

Invest Now

Valiant Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -310.1
  • PEG Ratio
  • -4.6
  • Market Cap Cr
  • 1,159
  • P/B Ratio
  • 1.6
  • Average True Range
  • 20.49
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.88
  • RSI
  • 46.95
  • MFI
  • 52.94

Valiant Organics Financials

Valiant Organics Technicals

EMA & SMA

Current Price
₹413.70
-5.6 (-1.34%)
pointer
  • stock-down_img
  • Bearish Moving Average 9
  • stock-up_img
  • Bullish Moving Average 7
  • 20 Day
  • ₹422.99
  • 50 Day
  • ₹405.13
  • 100 Day
  • ₹377.95
  • 200 Day
  • ₹369.18

Resistance and Support

417.6 Pivot Speed
  • R3 441.00
  • R2 434.50
  • R1 424.10
  • S1 407.20
  • S2 400.70
  • S3 390.30

What's your outlook on Valiant Organics?

You can only vote once!

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Valiant Organics manufactures and supplies specialty chemicals, including chlorophenols, acetophenones, and para nitro aniline. It serves industries like pharmaceuticals, agrochemicals, and dyes, providing high-quality chemical products to both domestic and international markets.

Valiant Organics has an operating revenue of Rs. 718.76 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 0% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 7%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 22% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 66 which is a FAIR score but needs to improve its earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 33 indicates it belongs to a strong industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Valiant Organics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-22 Audited Results
2025-02-13 Quarterly Results
2024-11-13 Quarterly Results
2024-08-13 Quarterly Results
2024-05-24 Audited Results
Date Purpose Remarks
2023-02-10 INTERIM Rs.1.00 per share(10%)Interim Dividend
2022-09-21 FINAL Rs.3.50 per share(35%)Final Dividend
View More

Valiant Organics F&O

Valiant Organics Shareholding Pattern

37.91%
0%
0.37%
37.41%
24.31%

About Valiant Organics

  • NSE Symbol
  • VALIANTORG
  • BSE Symbol
  • 540145
  • Managing Director
  • Mr. Sathiababu K Kallada
  • ISIN
  • INE565V01010

Similar Stocks to Valiant Organics

Valiant Organics FAQs

Valiant Organics share price is ₹413 As on 10 July, 2025 | 21:52

The Market Cap of Valiant Organics is ₹1158.6 Cr As on 10 July, 2025 | 21:52

The P/E ratio of Valiant Organics is -310.1 As on 10 July, 2025 | 21:52

The PB ratio of Valiant Organics is 1.6 As on 10 July, 2025 | 21:52

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23